AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Li...

FDA Drug Recall #D-0659-2024 — Class III — August 24, 2024

Recall Summary

Recall Number D-0659-2024
Classification Class III — Low risk
Date Initiated August 24, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Rubicon Research Private Limited
Location Ambarnath
Product Type Drugs
Quantity 3,984 bottles

Product Description

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Reason for Recall

Discoloration

Distribution Pattern

Nationwide in the US

Lot / Code Information

Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01

Other Recalls from Rubicon Research Private Limited

Recall # Classification Product Date
D-0517-2024 Class II Metoprolol Tartrate Tablets USP, 25mg, 1000 cou... May 6, 2024
D-0487-2024 Class II traMADol Hydrochloride Tablets, USP 50 mg, 1000... Apr 26, 2024
D-0362-2022 Class II Metoprolol Tartrate Tablets, USP 25 mg, 1000 - ... Dec 31, 2021

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.